Related Experiment Videos
[New perspective in the medical management of primary hyperparathyroidism]
1Clinique Endocrinologique Marc Linquette USNA, CHRU, 59037 Lille Cedex, France.
Annales D'Endocrinologie
|February 20, 2002
Abstract:
Most of the medical proposed for patients with primary hyperparathyroidism are inefficient or dangerous, with the exception of oestrogens and physiological doses of vitamin D in selected cases. PTH analogs, calcimimetic drugs and anti-PTH immunization now provide attractive management perspectives.